UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000060213 |
|---|---|
| Receipt number | R000068869 |
| Scientific Title | Confirmatory study of the effects of food component intake on blood flow |
| Date of disclosure of the study information | 2026/01/09 |
| Last modified on | 2025/12/26 16:00:07 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Confirmatory study of the effects of food component intake on blood flow
(SWE-2025-02)
Acronym
Confirmatory study of the effects of food component intake on blood flow
Scientific Title
Confirmatory study of the effects of food component intake on blood flow
Scientific Title:Acronym
Confirmatory study of the effects of food component intake on blood flow
Region
| Japan |
Condition
Condition
Not applicable
Classification by specialty
| Not applicable | Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Evaluate the impact of food intake on blood flow
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Exploratory
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Blood Flow
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Double blind -all involved are blinded
Control
Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
3
Purpose of intervention
Prevention
Type of intervention
| Food |
Interventions/Control_1
Consumption of test foods 1 and exercise intervention (6 weeks)
Interventions/Control_2
Consumption of test foods 2 and exercise intervention (6 weeks)
Interventions/Control_3
Consumption of control foods and exercise intervention (6 weeks)
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 64 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
1) Healthy men and women aged 20 to 64 years
2) Subjects who can understand the purpose and content of this study and agree in writing to participate in this study.
Key exclusion criteria
1) Subjects who are receiving some kind of treatment at the time of obtaining consent to participate in the study.
2) Subjects who keep irregular hours such as shift work.
3) Heavy drinker of alcohol.
4) Use of products affecting the data of this study, such as food for specified health use, food with function claims, and medicine.
5) Investigator's judgment for other reason.
Target sample size
90
Research contact person
Name of lead principal investigator
| 1st name | Daisuke |
| Middle name | |
| Last name | Takemoto |
Organization
Suntory Wellness Limited
Division name
Institute for Science of Life
Zip code
619-0284
Address
8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto, Japan
TEL
050-1804-0274
Daisuke_Takemoto@suntory.co.jp
Public contact
Name of contact person
| 1st name | Ryo |
| Middle name | |
| Last name | Kitamura |
Organization
Suntory Wellness Limited
Division name
Institute for Science of Life
Zip code
211-0067
Address
13-2, Imaikamicho, Nakahara-ku, Kawasaki, Kanagawa, Japan
TEL
050-1804-1951
Homepage URL
Ryo_Kitamura@suntory.co.jp
Sponsor or person
Institute
Suntory Wellness Limited
Institute
Department
Personal name
Funding Source
Organization
Suntory Wellness Limited
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Ueno-Asagao Clinic Ethical Review Committee
Address
6F Kairaku Building 2-7-5 Higashiueno Taito-ku Tokyo 110-0015, JAPAN
Tel
03-6240-1162
info@ueno-asagao.clinic
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2026 | Year | 01 | Month | 09 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2025 | Year | 12 | Month | 11 | Day |
Date of IRB
| 2025 | Year | 12 | Month | 10 | Day |
Anticipated trial start date
| 2026 | Year | 01 | Month | 09 | Day |
Last follow-up date
| 2026 | Year | 04 | Month | 20 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2025 | Year | 12 | Month | 26 | Day |
Last modified on
| 2025 | Year | 12 | Month | 26 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068869
